Myeloma Milestones: Selinexor May Be Next Novel Agent While Established Drugs Expand Indications

 
• By Mandy Jackson

Karyopharm's selinexor could be the next novel drug approved for multiple myeloma, which has seen a deluge of new treatment regimens. With room for improvement, the pipeline is full of milestones for approved and new therapies.

Open Book Of prostate multiple myeloma, Conceptual Image - Image
Several drugs are edging closer to approval. • Source: Shutterstock

More from New Products

More from Scrip